Differences

This shows you the differences between two versions of the page.

--- md_biochemistry [2026/09/21 10:13]
resident
+++ md_biochemistry [2026/09/22 06:19] (current)
resident
@@ Line 26: / Line 26: @@
 |22|:::|Instrument Purchase Vs Reagent rental/Cost per test|{{ ::2._mercury_blood_spillage.pptx |Spillage Management}} |
 |23|:::|Inventory Management System|{{ ::11._qms.pptx |QMS}}|
-|23|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}|
+|24|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}|
-|24|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL - 133|{{ ::use_and_implementation_of_nabl_symbol_as_per_nabl_-_133_in_medical_testing_laboratories.pptx |Use and Implementation of NABL Symbol as per NABL - 133 in Medical Testing Laboratories}}|
+|25|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL - 133|{{ ::use_and_implementation_of_nabl_symbol_as_per_nabl_-_133_in_medical_testing_laboratories.pptx |Use and Implementation of NABL Symbol as per NABL - 133 in Medical Testing Laboratories}}|
-|25|:::|FTIR|{{ ::ftir.pptx |FTIR-Principle}}|
+|26|:::|FTIR|{{ ::ftir.pptx |FTIR-Principle}}|
-|26|:::|Quality Policy vs Quality Objective|{{ ::quality_policy_vs_quality_objective_in_context_of_iso_151892022.pptx |Quality Policy vs Quality Objective in Context of ISO 151892022}}|
+|27|:::|Quality Policy vs Quality Objective|{{ ::quality_policy_vs_quality_objective_in_context_of_iso_151892022.pptx |Quality Policy vs Quality Objective in Context of ISO 151892022}}|
-|27|:::|VLDL Metabolism|{{ ::vldl_metabolism.pptx |VLDL Metabolism}}|
+|28|:::|VLDL Metabolism|{{ ::vldl_metabolism.pptx |VLDL Metabolism}}|
-|28|:::| |
+|29|:::|D-Dimer|{{ ::d-dimer.pptx |D-Dimer}}|
-|29|:::| |
 |30|:::| |
 |31|:::| |
-|24|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133|
+|32|:::| |
-|25|:::| |
+|33|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133|
-|26|:::| |
+|34|:::| |
+|35|:::| |
 |27|:::| |
 |28|:::| |